...Pharmaceuticals said China's State Food and Drug Administration (SFDA) approved a regulatory application from partner Rhei Pharmaceuticals Inc....
...cancer patients. Access said MuGard is expected to be launched in the "next couple quarters." Rhei...
...Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam from Access under a 2008 deal. Additionally, Rhei...

...up for approval in 2012. Source:BCIQ:BioCenturyOnlineIntelligence Company Product Indication Event Milestone Access Pharmaceuticals Inc. (OTCBB:ACCP)/ RHEI Pharmaceuticals Inc....

...Access Pharmaceuticals said partner Rhei Pharmaceuticals Inc. (Hong Kong, China) received an acceptance letter from China's State Food...
...Drug Administration (SFDA) for MuGard mucoadhesive oral rinse to treat and prevent oral mucositis (OM). Rhei...
...from SFDA this half. The acceptance triggered an undisclosed milestone payment from Rhei to Access. Rhei...

...single injection hyaluronic acid Osteoarthritis (OA) of the knee FDA action 2H10 AP Pharma Inc. (NASDAQ:APPA)/RHEI Pharmaceuticals Inc....

...OTCBB:RPBIF) 3M Rapid Detection RSV Test Detect respiratory syncytial virus (RSV) Pivotal trial data 1H09 Rhei...

...oral tibozole given once daily vs. Sporanox itraconazole in about 350 patients for 14 days. RHEI...
...which markets the product in Africa and Europe. J&J markets Sporanox to treat fungal infections. RHEI Pharmaceuticals Inc....

...FLML granted RHEI exclusive marketing rights to Asacard controlled-release aspirin in China, Taiwan, Hong Kong and...
...Hong Kong and Macau. Further terms were not disclosed. Flamel Technologies S.A. (FLML), Lyon, France RHEI Pharmaceuticals Inc....